Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VANI
VANI | US
1.30
USD0.01
0.78%
VANI | US
About VANI
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
1.30
Open
1.27
High
1.32
Low
1.23
Vivani Medical Inc. a clinical stage company develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville California.
View LessVANI | US
Risk
47.3
Sharpe
-0.03
Luna's Score
43/100
Recommendation
Sell
Luna says (VANI | US)
What's Working
Strength based on increasing price with high volume
What's not Working
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
36.0%1 month
47.3%3 months
68.9%6 months
65.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.02
Debt to equity
0.84
Debt to assets
0.42
Ent. to EBITDA
-3.93
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-24.90M
MarketCap
71.83M
MarketCap(USD)
71.83M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-86.10
Short ratio
8.90
Short perc.
2.98
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.20
Range1M
0.27
Range3M
0.61
Volumes: Market Activity
Rel. volume
1.04
Price X volume
279.41K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.93 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.02 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 68.94 | - | Par |
| Debt to Equity | 0.84 | -1.23 | Expensive |
| Debt to Assets | 0.42 | 0.25 | Expensive |
| Market Cap | 71.83M | - | Emerging |
